Transformative Angioplasty Sheath Platform Compatible with a Broad Range of Off-the-Shelf PTA and PTCA Angioplasty Balloons Cleared by FDA […]
Renew Biotechnologies is a dynamic holding company dedicated to acquiring, developing, and commercializing impactful biotechnology. […]
State legislators got a first hand look at Utah’s life sciences industry. […]
Temporary vessel occlusion a growing practice for trauma patients. […]
SINTX Technologies announced that its Board of Directors has initiated a process to explore potential strategic options for the Company. […]
Groundbreaking at-home pivotal trial of a much-anticipated therapeutic device is underway […]
Company has Achieved Prerequisites for Growing Test Adoption with FDA Authorization, Clinical Outcomes Data, Inclusion in Clinical Guidelines, and Broad Insurance Coverage […]
The Company expects that the application for OTC clearance will shortly be followed by pursuit of POC clearance, with other tests in the pipeline to meet the needs of a global market […]
New sponsored testing program leverages Myriad’s MyChoice Tests for patients with high-grade serous ovarian cancer […]
Owlet Expands Global Footprint with Launch of Medically-Certified Dream Sock™ in the UK and Across Europe […]
SINTX TECHNOLOGIES RECEIVES ADDITIONAL SBIR CONTRACT FOR 3D PRINTING TECHNOLOGY […]
VALENCIA, Calif. – June 7, 2024 – Nusano, Inc., a physics company transforming the production of medical radioisotopes, today announced industry veteran D. Scott Holbrook as chairman of its board. Holbrook is the co-founder of Invivo Molecular Imaging, and currently serves as the general manager and chief strategy officer for Pharmalogic, a leading contract development […]